Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
bupivacainhydrochlorid 0,1 % infusionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 0,125 % infusionsvæske, opløsning, pose a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 0,75 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 0,1 % infusionsvæske, opløsning, pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 0,1 % infusionsvæske, opløsning, pose a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + fentanyl |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + fentanyl 0,1%/2µg/mL injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 5 mg + adrenalin 5 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 2,5 mg + adrenalinbitartrat 5 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid + adrenalin 0,5 %/50 µg/10 ml (1:200.000) injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride monohydrate (substance) |
Is a |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Bupivacaine hydrochloride monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely bupivacaine hydrochloride 50 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 50 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 312.5 milligram/250 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 312.5 milligram/250 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 25 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 25 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 2.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 2.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 1.25 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 1.25 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.05 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.05 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.25 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.25 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.25 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride 1.25 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
1 |
Bupivacaine hydrochloride anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Bupivacaine hydrochloride |
Inferred relationship |
Some |
|